Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 5/20 | 0.39 |
| ▸ | CPA1 | P15085 | 3/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | GSR | P00390 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL809461 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CYP3A4NPC1ADAM17MEN1 | |
| SCHEMBL809606 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CYP3A4NPC1ADAM17MEN1 | |
| SCHEMBL809532 | 0.86 | ALDH1A1 (0.43) | ALDH1A1CYP3A4MEN1KMT2AMAPT | |
| SCHEMBL809493 | 0.86 | ALDH1A1 (0.43) | ALDH1A1CYP3A4MEN1KMT2AMAPT | |
| SCHEMBL813624 | 0.86 | ALDH1A1 (0.43) | ALDH1A1CYP3A4MEN1KMT2AMAPT | |
| SCHEMBL1319211 | 0.84 | ALDH1A1 (0.38) | ALDH1A1CYP3A4NPC1MEN1KMT2A | |
| SCHEMBL1319209 | 0.84 | ALDH1A1 (0.38) | ALDH1A1CYP3A4NPC1MEN1KMT2A | |
| SCHEMBL27165030 | 0.84 | ALDH1A1 (0.38) | ALDH1A1CYP3A4NPC1MEN1KMT2A | |
| SCHEMBL27204537 | 0.84 | ALDH1A1 (0.37) | ALDH1A1CYP3A4MEN1KMT2AMAPT | |
| SCHEMBL27165110 | 0.84 | ALDH1A1 (0.42) | ALDH1A1CYP3A4MAPTKDM4EMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4651954-A1 | INHIBITORS OF MPTP | NRG Therapeutics LTD (GB) | 2025-11-26 | — | — | EP | disclosed |
| WO-2024153945-A1 | INHIBITORS OF MPTP | NRG THERAPEUTICS LTD (GB) | 2024-07-25 | — | — | WO | disclosed |
| US-9206090-B2 | Tricyclic chiral compounds and their use in asymmetric catalysis | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2015-12-08 | — | — | US | disclosed |
| CN-102203097-B | Three ring chipal compounds and the purposes in asymmetry catalysis thereof | NANYANG TECHNOLOGICAL UNIVERSITY SINGAPORE (SG) | 2015-08-26 | — | — | CN | disclosed |
| US-20110269972-A1 | NOVEL TRICYCLIC CHIRAL COMPOUNDS AND THEIR USE IN ASYMMETRIC CATALYSIS | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2011-11-03 | — | — | US | disclosed |
| CN-102203097-A | Novel tricyclic chiral compounds and their use in asymmetric catalysis | UNIV NANYANG | 2011-09-28 | — | — | CN | disclosed |
| US-8008508-B2 | Organocatalyst | NATIONAL TAIWAN NORMAL UNIVERSITY (TW) | 2011-08-30 | — | — | US | disclosed |
| US-7968734-B2 | Organocatalysts and methods of use in chemical synthesis | STC.UNM (US) | 2011-06-28 | — | — | US | disclosed |
| US-20110040104-A1 | ORGANOCATALYST | NATIONAL TAIWAN NORMAL UNIVERSITY (TW) | 2011-02-17 | — | — | US | disclosed |
| WO-2010027334-A1 | NOVEL TRICYCLIC CHIRAL COMPOUNDS AND THEIR USE IN ASYMMETRIC CATALYSIS | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2010-03-11 | — | — | WO | disclosed |
| US-20070244328-A1 | Organocatalysts and Methods of Use in Chemical Synthesis | STC.UNM (US) | 2007-10-18 | — | — | US | disclosed |
| WO-2006007586-A1 | ORGANOCATALYSTS AND METHODS OF USE IN CHEMICAL SYNTHESIS | SCIENCE & TECHNOLOGY CORPORATION @ UNM (US) | 2006-01-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070244328-A1 | Organocatalysts and Methods of Use in Chemical Synthesis | SCO2, CBR1, CBR3 | ALDH1A1 1287/4885CYP3A4 231/4885NPC1 902/4885 |
| US-20110269972-A1 | NOVEL TRICYCLIC CHIRAL COMPOUNDS AND THEIR USE IN ASYMMETRIC CATALYSIS | SCO2, CBR3, HCCS | ALDH1A1 3150/4885CYP3A4 4/4885NPC1 2896/4885 |
| US-20110040104-A1 | ORGANOCATALYST | C1S, C5, H1-0 | ALDH1A1 1316/4885CYP3A4 34/4885NPC1 3334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.